Bangalore, India -- (SBWIRE) -- 01/23/2018 -- The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking. The scientific community hypothesizes that the DENV evolved in nonhuman primates from where it spread to humans first in Southeast Asia and Africa and then to other parts of the world.

Report forecast the global dengue vaccine market to grow at a CAGR of 15.05% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global dengue vaccine market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Dengue Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GlaxoSmithKline
- Merck Sharp & Dohme
- Sanofi
- Takeda Pharmaceuticals

Other prominent vendors
- GeneOne Life Sciences
- Medigen Biologics
- Panacea Biotec
- Sun Pharmaceutical

Market driver
- Rapid growth in disease prevalence
- For a full, detailed list, view our report

Market challenge
- Regulatory hurdles in vaccine penetration
- For a full, detailed list, view our report

Market trend
- Licensing deals
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?

Spanning over 78 pages "Global Dengue Vaccine Market 2017 - 2021" report covers Executive Summary, Scope Of The Report, Research Methodology, Introduction, Market Landscape, Five Forces Analysis, Pipeline Analysis, Market Segmentation By End-User, Market Segmentation By Vaccine Type, Regional Landscape, Decision Framework, Drivers And Challenges, Market Trends, Vendor Landscape, Key Vendor Analysis, Appendix.

For more information Visit at: https://www.drugpipeline.net/technavio/global-dengue-vaccine-market-2017-2021

Find all Pharma and Healthcare Reports at - http://www.drugpipeline.net/catalog/pharma-healthcare

Related Reports;

Global Female Fertility and Pregnancy Rapid Test Market 2017-2021 - Visit at - https://www.drugpipeline.net/technavio/global-female-fertility-and-pregnancy-rapid-test-market-2017-2021

Global Lung Cancer Liquid Biopsy Market 2017-2021 - Visit at - https://www.drugpipeline.net/technavio/global-lung-cancer-liquid-biopsy-market-2017-2021

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.